Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Progress in psoriasis therapy via novel drug delivery systems

    Nitha Vincent, Ramya Devi D, Vedha Hari BN
    08-09-2014
    https://doi.org/10.4081/dr.2014.5451
    3905
    PDF: 2229
    HTML: 705
  • Treatment of flat warts with trifarotene

    Gaetano Licata, Eugenia Veronica Di Brizzi, Elisabetta Fulgione, Graziella Babino, Vittorio Tancredi, Filomena Barbato, Giuseppe Argenziano, Caterina Mariarosaria Giorgio
    10-11-2025
    https://doi.org/10.4081/dr.2025.10284
    1325
    PDF: 653
    HTML: 16
  • Cutaneous squamous cell carcinoma of the lip successfully treated with rhenium-188 brachytherapy

    Chiara Sabbadini, Federico Patta, Leda Lorenzon, Mohsen Farsad, Carla Nobile
    14-06-2023
    https://doi.org/10.4081/dr.2023.9560
    765
    PDF: 490
    HTML: 20
  • Spitz melanocytoma with AKAP9::BRAF fusion: clinicopathologic and molecular insights

    Laura Grigolato, Mariachiara Arisi, Iacopo Ghini, Martina Perantoni, Simone Soglia, Cesare Ariasi, Giuseppe La Rosa, Francesca Di Lauro, Benedetta Galli, Simone Viola, Piergiacomo Calzavara-Pinton
    12-12-2025
    https://doi.org/10.4081/dr.2025.10633
    699
    PDF: 404
    HTML: 0
  • Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma

    Luigi Scarpato, Marco Palla, Sabino Strippoli, Luca Tagliaferri, Luca Fania, Maristella Saponara, Anna Carbone, Francesco Spagnolo, Flavia Silvestri, Paolo Antonio Ascierto
    03-07-2024
    https://doi.org/10.4081/dr.2024.9882
    1230
    PDF: 669
    HTML: 140
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    942
    PDF: 489
    HTML: 55
  • COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports

    Angelo Massimiliano D'Erme, Cristian Fidanzi, Marco Romanelli, Valentina Dini, Giovanni Bagnoni, Agata Janowska
    24-08-2023
    https://doi.org/10.4081/dr.2023.9763
    844
    PDF: 445
    HTML: 39
  • A rare case of keloid combined with bullous pemphigoid

    Ying Zhang, Yiyi Gong, Xiangguang Shi, Huyan Chen, Yining Wei, Wenyu Wu, Mengguo Liu
    09-10-2025
    https://doi.org/10.4081/dr.2025.10484
    1196
    PDF: 318
    HTML: 11
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2549
    PDF: 1466
    HTML: 129
  • Giant basal cell carcinoma of the scalp: rotation advancement flap as a successful dermatosurgical approach

    Georgi Tchernev, Simona Kordeva, Ilia Lozev
    02-03-2023
    https://doi.org/10.4081/dr.2023.9664
    908
    PDF: 531
    HTML: 42
  • Growth hormone deficiency and secondary adrenal insufficiency in petrified ear syndrome: a case report and literature review

    Sebastiano Recalcati, Alberto Vassallo, Marta Villanova, Roberto Lanzi, Marco Losa, Maria Grazia Patricelli, Paola Carrera, Fabrizio Fantini
    31-01-2025
    https://doi.org/10.4081/dr.2025.10263
    495
    PDF: 306
    HTML: 33
  • 35 | Real-world outcomes of targeted therapy in stage IV melanoma after relapse on adjuvant dabrafenib and trametinib: insights from a single-center cohort Rossella Villani, Chiara Bungaro, Anna Cecere, Ileana De Roma, Sabino Strippoli, Michele Guida | Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

    Italian Melanoma Intergroup
    11-12-2025
    https://doi.org/10.4081/dr.2025.10777
    462
  • Multiple non-syndromic basal cell carcinoma with the chest as primary site and lung metastases: A rare case

    Konstantinos Roditis, George Metaxas, Ourania Neofotistou, Kleo Papaparaskeva, Aikaterini Koutsoumbi, Konstantinos Louis
    05-08-2021
    https://doi.org/10.4081/dr.2021.9106
    2373
    PDF: 543
    HTML: 34
  • Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

    Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong
    17-03-2022
    https://doi.org/10.4081/dr.2022.9444
    1258
    PDF: 633
    HTML: 31
  • A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project

    Francesco Cusano, Francesca Sampogna, Alexandra Maria Giovanna Brunasso Vernetti, Stefano Stisi, Gilda Sandri, Giovanna Malara, Luigi Naldi, Michele Pellegrino, Giovanni Luigi Tripepi, Umberto di Luzio Paparatti, Concetto Paolo Agnusdei, Claudio Bonifati, Antonella Celano, Valeria Corazza, Federica D'Agostino, Rocco De Pasquale, Emilio Filippucci, Rosario Foti, Giovanna Galdo, Fabiana Gai, Giulia Ganzetti, Dario Graceffa, Mara Maccarone, Annamaria Mazzotta, Gennaro Melchionda, Francesca Molinaro, Franco Paoletti, Silvia Tonolo, Adriano Vercellone, Rosetta Vitetta, Cesare Massone, Gian Domenico Sebastiani
    26-09-2022
    https://doi.org/10.4081/dr.2022.9541
    1326
    PDF: 731
    HTML: 48
  • Keratolysis exfoliativa-like eruption induced by ranolazine

    Elena Pierobon, Lerica Germi, Andrea Sechi, Giampaolo Trevisan, Elena Pezzolo, Claudio Feliciani, Luigi Naldi
    22-03-2022
    https://doi.org/10.4081/dr.2022.9264
    3570
    PDF: 618
    HTML: 178
  • 61 | SUNITINIB-INDUCED FOLLICULAR OCCLUSION DISORDER OF THE FACE: A CASE REPORT Z. Fratton1|2, A. Bolzon2|3, A. Corrà2, G. Frattin2|3, L. Germi2, L. Gnesotto2, D. Lai2, G. Mioso2, E. Pezzolo2, L. Schiesari2 | 1Department of Medicine, Institute of Dermatology, University of Udine, Italy; 2Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; 3Unit of Dermatology, Department of Medicine, University of Padova, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11070
    218
    PDF: 147
  • 34 | Dissecting the spectrum of rare BRAF mutations in melanoma: a nation-wide study by the Italian Melanoma Intergroup Francesco Spagnolo1|2, Bruna Dalmasso3, Maria Chiara Scaini4, Laura Cendron5, Monica Rodolfo6, Ilaria Mattavelli7, Elena Tamborini8, Francesca Collina9, Gerardo Ferrara, Gabriele Madonna10, Carlo Cota11, Elisa Melucci12, Stefania Tommasi13, Martina Ubaldi14, Roberta Depenni15, Andrea Carugno16, Riccardo Marconcini17, Laura Orgiano18, Maurizio Lombardo19, Simona Sola20, Cristina Pellegrini21, Francesca Castiglione22, Matteo Gasparotto5|23, Alireza Jorkesh5, Stefania Pellegrini4, Edoardo Raposio1, Andrea Boutros2, Enrica Teresa Tanda2, Michele Guida25, Pietro Quaglino26, Giuseppe Palmieri27, Daniela Massi22, Paolo Antonio Ascierto10, Mario Mandalà*28, Chiara Menin*4, Paola Ghiorzo*24, Lorenza Pastorino*24, for the Italian Melanoma Intergroup29 | 1Department of Surgical Sciences and Integrated Diagnostics, DISC, Plastic Surgery Division, University of Genoa; 2IRCCS Ospedale Policlinico San Martino, Genova; 3IRCCS Ospedale Policlinico San Martino, Cancer Genetics, Genoa; 4Immunology and Molecular Oncology Unit, Veneto Institute of Oncology - IOV IRCCS, Padua; 5Department of Biology, University of Padua, Padua; 6Unit of Translational Immunology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 7Melanoma Surgical Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 8Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 9Pathology Unit, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Napoli; 10Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli; 11Dermatopathology Unit, San Gallicano Dermatological Institute IRCCS, Rome; 12Pathology Unit, IRCCS Regina Elena, National Cancer Institute, Rome; 13Molecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari; 14Unit of Medical Oncology, University of Perugia; 15Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena; 16Department of Medicine and Surgery, University of Insubria, Varese; 17Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa; 18Department of Medical Oncology, University of Cagliari, Cagliari; 19Division of Dermatology, Department of Medicine and Surgery, Ospedale di Circolo e Fondazione Macchi, ASST dei Sette Laghi, Varese; 20Surgical Pathology, Galliera Hospital, Genoa; 21Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila; 22Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy and Section of Pathology, Department of Health Sciences, University of Florence, Italy; 23Department of Translational Brain Research, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. 24Department of Internal Medicine and Medical Specialties, University of Genoa; 25Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, Bari; 26Dermatology Clinic, Department of Medical Sciences, University of Turin; 27Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari - Unit of Cancer Genetics, IRGB-CNR, Sassari; 28University of Perugia, Medical Oncology Unit, Santa Maria Misericordia Hospital, Perugia; 29Italian Melanoma Intergroup, IMI, Italy. *These authors equally contributed to this work.

    Italian Melanoma Intergroup
    11-12-2025
    https://doi.org/10.4081/dr.2025.10776
    438
  • A bibliometric study of the top 100 most-cited articles on melanoma: insights into research trends and characteristics

    Jinhao Zhang, Xiangze Meng, Yun Wang, Wei Liu
    18-08-2025
    https://doi.org/10.4081/dr.2025.10435
    621
    PDF: 348
    SUPPLEMENTARY MATERIAL: 194
    HTML: 22
  • 36 | Neoadjuvant strategy for locally advanced conjunctival melanoma: a single-center approach to eye preservation F. Rifaldi1|2, M. Angi3, L. Giuseppe1, F. Lanza3, A. Spagnoletti1, J. Sergenti3, A. Indini1, E. Mastrogiuseppe3, M. Del Vecchio1, L. Di Guardo1 | 1Melanoma Medical Oncology Unit, Department of Medical Oncology ed Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 2Fondazione IRCCS Policlinico San Matteo, Pavia; 3Ocular Oncology Service, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

    Italian Melanoma Intergroup
    11-12-2025
    https://doi.org/10.4081/dr.2025.10778
    539
  • Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus

    Andrea Bassi, Vincenzo Piccolo, Grazia Gallippi, Giuseppe Argenziano, Michela Magnano, Carlo Mazzatenta
    11-09-2025
    https://doi.org/10.4081/dr.2025.10458
    478
    PDF: 381
    HTML: 26
  • Genetic variations in the ST18 gene and their association with pemphigus vulgaris in Vietnamese patients: insights from a case series

    Thi Xuan Tam Huynh, Long Phan Son
    22-04-2025
    https://doi.org/10.4081/dr.2025.10265
    544
    PDF: 296
    HTML: 18
  • Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

    Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    12-11-2024
    https://doi.org/10.4081/dr.2024.10080
    1433
    PDF: 777
    HTML: 52
  • 52 | ADULT LANGERHANS CELL HISTIOCYTOSIS: A DERMATOLOGICAL DIAGNOSTIC CHALLENGE UNVEILING MULTISYSTEM DISEASE M. Donati1, A. Corrà2, A. Verdelli3, N. Pimpinelli3, C. Longo1, M. Caproni3 | 1Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; 2Dermatology Unit, Ospedale San Bartolo, Vicenza, Italy; 3Section of Dermatology, Department of Health Sciences, University of Florence, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11068
    163
    PDF: 144
  • Erythema nodosum-like panniculitis during BRAF inhibitor therapy for melanoma: never forget latent tuberculosis infection

    Alba Guglielmo, Lorenzo D'Alì, Maria Ludovica Deotto, Alessia Cimadamore, Gaetano Pascoletti, Elena Poletto, Alessandro Minisini
    04-06-2026
    https://doi.org/10.4081/dr.2026.10380
    557
    PDF: 355
26 - 50 of 73 items << < 1 2 3 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.